Evidence map›Paper›PMID 36545067›Full record

ArticleRSC advances2022

Synthesis of bimetal MOFs for rapid removal of doxorubicin in water by advanced oxidation method.

Junhao Hu, Qiong Yi, Ziyi Xiao, Feng Tian, Tingting Shu, Xiaolan Liu, Yingxi Wang, Ling Li, Jiangang Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Removal of pharmaceutical pollutants by adsorption onto novel metal-organic frameworks.Environmental science and pollution research international · 2025
    Review
  2. Review
  3. Magnetic MnFeRSC advances · 2024
    Article
  4. Ultra-small CoRSC advances · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Junhao HuMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.ORCID https://orcid.org/0000-0003-2682-8765
Qiong YiMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.
Ziyi XiaoMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.
Feng TianMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.ORCID https://orcid.org/0000-0001-8747-3959
Tingting ShuMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.
Xiaolan LiuMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.
Yingxi WangMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.
Ling LiMinistry-of-Education Key Laboratory for the Synthesis and Application of Organic Function Molecules, Hubei University 430062 China lingli@hubu.edu.cn.ORCID https://orcid.org/0000-0002-2046-3462
Jiangang ZhouFaculty of Resources and Environmental Science, Hubei University 430062 China 497966492@qq.com.
Hubei University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxorubicin (DOX) has been an emerging environmental pollutant due to its significant genotoxicity to mankind. Advanced oxidation processes are a potential strategy to remove DOX in water solution. To develop a highly efficient catalytic agent to remove DOX, bimetal MOFs were synthesized, with Cu

Identifiers

PMID36545067
PMCPMC9748979
OpenAlexW4312113009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.